Bicycle Therapeutics PLC expected to post a loss of $1.29 a share - Earnings Preview

Bicycle Therapeutics

31/07/2023 19:32

* Bicycle Therapeutics PLC  BCYC.OQ   BCYC.O  is expected
to show
a rise in quarterly revenue when it reports  results on August 2
(estimated). 
    * The Cambridge Cambridgeshire-based  company is expected to
report  a 4.7% increase in revenue to $4.584 million from $4.38
million a year ago, according to the mean estimate from 10
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Bicycle
Therapeutics PLC
is for a loss of $1.29 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Bicycle
Therapeutics PLC is $50​, above​ its last closing price
of $24.66. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -1.08       -1.07      -1.30     Missed  -21.1
 Dec. 31 2023  -1.05       -1.06      -1.01     Beat    4.6
 Sep. 30 2022  -0.86       -0.89      -0.96     Missed  -8​
 Jun. 30 2022  -0.89       -0.85      -0.90     Missed  -6.1
 ​​Mar.        -0.70       -0.68      -0.93     Missed  -36.4
 31 2022                                                
 Dec. 31 2021  -0.67       -0.61      -0.63     Missed  -3.1​
 Sep. 30 2021  -0.63       -0.61      -0.59     Beat    3.5
 Jun. 30 2021  -0.68       -0.73      -0.74     Missed  -1.9
 This summary was machine generated July 31 at 18:31 GMT.  All
figures in US dollars  unless otherwise stated